- $36.28m
- $26.24m
- $0.04m
Annual balance sheet for RenovoRx, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1.79 | 15.2 | 6.44 | 1.17 | 7.15 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | — | — | — | — | 0.043 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1.91 | 16.3 | 7.26 | 1.47 | 7.83 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | — | 0.006 | 0 | — | 0.29 |
| Other Long Term Assets | |||||
| Total Assets | 1.91 | 16.3 | 7.26 | 1.47 | 8.12 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 4.1 | 0.938 | 1.1 | 1.18 | 1.91 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 4.12 | 0.938 | 1.1 | 4.47 | 3.64 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -2.21 | 15.3 | 6.16 | -3 | 4.48 |
| Total Liabilities & Shareholders' Equity | 1.91 | 16.3 | 7.26 | 1.47 | 8.12 |
| Total Common Shares Outstanding |